The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

We recently published a list of Jim Cramer Tells Viewers To Not Trust Billionaires & Discusses These 11 Stocks. In this ...

In a report released today, Jessica Tassan from Piper Sandler maintained a Buy rating on Cigna (CI – Research Report), with a price target of ...

To make our list of the stocks that Jim Cramer talked about, we listed down the stocks he mentioned during CNBC’s Squawk on ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” fourth quarter 2024 investor ...

Shares of The Cigna Group traded about 0.8% lower in volatile action Monday morning as Wall Street analysts continued to ...

Shares of Cigna (NYSE: CI) were dropping Thursday. While Cigna's Q4 revenue of $65.65 billion beat Wall Street's estimate of $63.44, rising medical costs led to a much more significant earnings ...

Leading health insurer Cigna Group Inc. (NYSE: CI) was praised for having the foresight to divest its Medicare Advantage (MA) ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Representatives of the Elon Musk-run Department of Government Efficiency have gained access to key payment and contracting systems of the U.S. Centers for Medicare and Medicaid Services in a bid to ...